Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 2013

View Archived Issues

Elimination of leukemia stem cells observed for PF-04449913

Novel oncolytic agents with epigenetic targets described

Shire updates accomplishments of fourth quarter 2012

Small molecules targeting RNA improve experimental myotonic dystrophy type 1

Trial of temsirolimus in prostate cancer stopped prematurely

Boehringer Ingelheim divulges new LTA-4 hydrolase inhibitors

Georgia State University patents novel cyanine dyes for cancer

Abbott Laboratories prepares new protein kinase inhibitors

German group discloses novel TRPV1 ligands

Researchers at Allergan disclose novel alpha2-adrenoceptor agonists

CS-6 shows activity against ovarian cancer stem cells

PIQUR Therapeutics secures funding to develop innovative anticancer therapies

Roche and Chiasma enter into a collaboration agreement for Octreolin

FDA grants orphan drug status to SOV's testosterone undecanoate

Idursulfase beta gains orphan drug status in U.S.

FDA grants orphan drug status to diabetes vaccine candidate

Regeneron and Bayer initiate new phase III aflibercept study

FDA accepts lixisenatide NDA for review

Theracrine synthesizes new fascin inhibitors for cancer

Vorsetuzumab mafodotin shows promising activity in patients with CD70-positive RCC

Edison reports initiation of phase II study of EPI-743

New androgen receptor agonists divulged by Novartis

Novel inhibitors of tankyrase synthesized at Novartis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...